<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6832241\results\search\disease\results.xml">
  <result pre="most effective strategy to prevent such infections and/or to reduce" exact="viral disease." post="Two major types of influenza vaccines are approved for"/>
  <result pre="infections and/or to reduce viral disease. Two major types of" exact="influenza" post="vaccines are approved for human use: inactivated influenza vaccines"/>
  <result pre="types of influenza vaccines are approved for human use: inactivated" exact="influenza" post="vaccines (IIVs) and live attenuated influenza vaccines (LAIVs). Two"/>
  <result pre="for human use: inactivated influenza vaccines (IIVs) and live attenuated" exact="influenza" post="vaccines (LAIVs). Two Master Donor Virus (MDV) backbones have"/>
  <result pre="Virus (MDV) backbones have been used to create LAIVs against" exact="influenza" post="A virus (IAV): the United States (US) A/Ann Arbor/6/60"/>
  <result pre="compared the In vitro and in vivo phenotype of recombinant" exact="influenza" post="A/Puerto Rico/8/34 H1N1 (PR8) viruses containing the ts, ca"/>
  <result pre="development of improved LAIVs for the prevention of IAV infections." exact="influenza" post="vaccine live-attenuated vaccine 1. Introduction In the United States"/>
  <result pre="Centers for Disease Control and Prevention (CDC) has estimated that" exact="influenza" post="has caused between 9.3 and 49.0 million illnesses each"/>
  <result pre="between 12,000 and 79,000 deaths annually [1]. Two types of" exact="influenza" post="cause seasonal, global epidemics in human populations each year:"/>
  <result pre="influenza cause seasonal, global epidemics in human populations each year:" exact="influenza" post="A virus (IAV) and influenza B virus (IBV) [2,3]."/>
  <result pre="in human populations each year: influenza A virus (IAV) and" exact="influenza" post="B virus (IBV) [2,3]. IAVs can also cause sporadic"/>
  <result pre="humans [4]. Vaccination is the most cost-effective approach to prevent" exact="influenza" post="infections [5]. Currently, three major influenza vaccines are approved"/>
  <result pre="cost-effective approach to prevent influenza infections [5]. Currently, three major" exact="influenza" post="vaccines are approved for human use in the US:"/>
  <result pre="use in the US: recombinant (r) hemagglutinin (HA) protein, inactivated" exact="influenza" post="vaccines (IIVs) and live attenuated influenza vaccines (LAIVs) [1]."/>
  <result pre="hemagglutinin (HA) protein, inactivated influenza vaccines (IIVs) and live attenuated" exact="influenza" post="vaccines (LAIVs) [1]. IIVs are delivered by the intramuscular"/>
  <result pre="HA protein [6,7,8], one of the major antigenic determinants of" exact="influenza" post="viruses which is responsible for viral entry [9]. On"/>
  <result pre="the introduction of the quadrivalent vaccine formulation during the 2013–2014" exact="influenza" post="season, different studies revealed less than expected effectiveness of"/>
  <result pre="over LAIV over IIVs. LAIVs have been generated by passaging" exact="influenza" post="viruses at gradually reduced temperatures in eggs or cultured"/>
  <result pre="of these viral variants was based on the ability of" exact="influenza" post="viruses to replicate in the upper (25–33 °C) and"/>
  <result pre="AA and the Russian Len MDVs using the backbone of" exact="influenza" post="PR8 In vitro and in vivo. Our results show"/>
  <result pre="recombinant virus containing the HA and NA viral segments of" exact="influenza" post="A/Hong Kong/1/1968 H3N2 in the background of PR8 virus"/>
  <result pre="cells at 33 °C using a monoclonal antibody (mAb) against" exact="influenza" post="virus nucleoprotein, NP (ATCC HB-65, HL16-L10-4R5); as described [46]."/>
  <result pre="collected by submandibular bleeding to evaluate the presence of total" exact="influenza" post="antibodies (Abs) by enzyme-linked immunosorbent assay (ELISA) and hemagglutination"/>
  <result pre="of the Russian Len MDV (Figure 9). Using a bat" exact="influenza" post="A virus polymerase structure solved by X-ray crystallography as"/>
  <result pre="US AA MDV can attenuate a broad range of other" exact="influenza" post="viral strains, including human [35], canine [11,12,21] and equine"/>
  <result pre="remains to be determined whether this also applies to different" exact="influenza" post="virus strains and/or subtypes. Nevertheless, our results have important"/>
  <result pre="and improved LAIVs for the treatment of human and/or animal" exact="influenza" post="infections. Specifically, our findings with PR8 suggest that it"/>
  <result pre="Care Med.20072814415810.1055/s-2007-97648717458769 3.BarrI.G.McCauleyJ.CoxN.DanielsR.EngelhardtO.G.FukudaK.GrohmannG.HayA.KelsoA.KlimovA.et al.Epidemiological, antigenic and genetic characteristics of seasonal" exact="influenza" post="A(H1N1), A(H3N2) and B influenza viruses: Basis for the"/>
  <result pre="and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: Basis for the WHO recommendation on the composition"/>
  <result pre="viruses: Basis for the WHO recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 Northern Hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635"/>
  <result pre="4.SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.MaS.K.CheungC.L.RaghwaniJ.BhattS.et al.Origins and evolutionary genomics of the 2009 swine-origin H1N1" exact="influenza" post="A epidemicNature20094591122112510.1038/nature0818219516283 5.PicaN.PaleseP.Toward a universal influenza virus vaccine: Prospects"/>
  <result pre="the 2009 swine-origin H1N1 influenza A epidemicNature20094591122112510.1038/nature0818219516283 5.PicaN.PaleseP.Toward a universal" exact="influenza" post="virus vaccine: Prospects and challengesAnnu. Rev. Med.20136418920210.1146/annurev-med-120611-14511523327522 6.BelongiaE.A.KiekeB.A.DonahueJ.G.GreenleeR.T.BalishA.FoustA.LindstromS.ShayD.K.Effectiveness of"/>
  <result pre="virus vaccine: Prospects and challengesAnnu. Rev. Med.20136418920210.1146/annurev-med-120611-14511523327522 6.BelongiaE.A.KiekeB.A.DonahueJ.G.GreenleeR.T.BalishA.FoustA.LindstromS.ShayD.K.Effectiveness of inactivated" exact="influenza" post="vaccines varied substantially with antigenic match from the 2004–2005"/>
  <result pre="to the 2006–2007 seasonJ. Infect. Dis.200919915916710.1086/59586119086915 7.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 8.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok,"/>
  <result pre="systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 8.CoxM.M.PatriarcaP.A.TreanorJ.FluBlok, a recombinant hemagglutinin" exact="influenza" post="vaccineInfluenza Other Respir Viruses2008221121910.1111/j.1750-2659.2008.00053.x19453397 9.PaleseP.S.MeganL.Fields Virology5th ed.Lippincott Williams &amp;amp;"/>
  <result pre="Williams &amp;amp; WilkinsPhiladelphia, PA, USA2007Volume 2 10.HoftD.F.BabusisE.WorkuS.SpencerC.T.LottenbachK.TruscottS.M.AbateG.SakalaI.G.EdwardsK.M.CreechC.B.et al.Live and inactivated" exact="influenza" post="vaccines induce similar humoral responses, but only live vaccines"/>
  <result pre="in young childrenJ. Infect. Dis.201120484585310.1093/infdis/jir43621846636 11.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.A temperature sensitive live-attenuated canine" exact="influenza" post="virus H3N8 vaccineJ. Virol.20169110.1128/JVI.02211-16 12.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine"/>
  <result pre="live-attenuated canine influenza virus H3N8 vaccineJ. Virol.20169110.1128/JVI.02211-16 12.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 13.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a"/>
  <result pre="vaccineJ. Virol.20169110.1128/JVI.02211-16 12.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 13.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine influenza virus live-attenuated"/>
  <result pre="for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 13.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine" exact="influenza" post="virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 14.MaassabH.F.Adaptation and growth characteristics of influenza"/>
  <result pre="equine influenza virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 14.MaassabH.F.Adaptation and growth characteristics of" exact="influenza" post="virus at 25 degrees cNature196721361261410.1038/213612a06040602 15.AleksandrovaG.I.MikutskaiaB.A.PleshanovaR.A.PanovaN.G.SmorodintsevA.A.The reactive and immunogenic"/>
  <result pre="reactive and immunogenic properties and epidemiological effectiveness of further attenuated" exact="influenza" post="virus vaccinal strains (observed in preschool children)Vopr. Virusol.19651067735865829 16.WilsonW.D.RobinsonD.Field"/>
  <result pre="children)Vopr. Virusol.19651067735865829 16.WilsonW.D.RobinsonD.Field safety of a modified-live, cold-adapted intranasal equine" exact="influenza" post="vaccine (HESKAFlu Avert IN vaccine) in horsesJ. Equine Vet."/>
  <result pre="Vet. Sci.20002081010.1016/S0737-0806(00)80310-X 17.YoungnerJ.S.Whitaker-DowlingP.ChambersT.M.RushlowK.E.SebringR.Derivation and characterization of a live attenuated equine" exact="influenza" post="vaccine virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 18.ChanW.ZhouH.KembleG.JinH.The cold adapted and"/>
  <result pre="virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 18.ChanW.ZhouH.KembleG.JinH.The cold adapted and temperature sensitive" exact="influenza" post="A/Ann Arbor/6/60 virus, the master donor virus for live"/>
  <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
  <result pre="19.MurphyB.R.CoelinghK.Principles underlying the development and use of live attenuated cold-adapted" exact="influenza" post="A and B virus vaccinesViral Immunol.20021529532310.1089/0882824026006624212081014 20.KohlmeierJ.E.WoodlandD.L.Immunity to respiratory"/>
  <result pre="Immunol.20021529532310.1089/0882824026006624212081014 20.KohlmeierJ.E.WoodlandD.L.Immunity to respiratory virusesAnnu. Rev. Immunol.200927618210.1146/annurev.immunol.021908.13262518954284 21.RodriguezL.NogalesA.MurciaP.R.ParrishC.R.Martinez-SobridoL.A bivalent live-attenuated" exact="influenza" post="vaccine for the control and prevention of H3N8 and"/>
  <result pre="for the control and prevention of H3N8 and H3N2 canine" exact="influenza" post="virusesVaccine2017354374438110.1016/j.vaccine.2017.06.06028709557 22.ChengX.ZengelJ.R.SuguitanA.L.Jr.XuQ.WangW.LinJ.JinH.Evaluation of the humoral and cellular immune responses"/>
  <result pre="cellular immune responses elicited by the live attenuated and inactivated" exact="influenza" post="vaccines and their roles in heterologous protection in ferretsJ."/>
  <result pre="in heterologous protection in ferretsJ. Infect. Dis.201320859460210.1093/infdis/jit20723656978 23.VictorS.T.WatanabeS.KatsuraH.OzawaM.KawaokaY.A replication-incompetent PB2-knockout" exact="influenza" post="A virus vaccine vectorJ. Virol.201210.1128/JVI.06232-11 24.De VilliersP.J.SteeleA.D.HiemstraL.A.RappaportR.DunningA.J.GruberW.C.ForrestB.D.Efficacy and safety"/>
  <result pre="vectorJ. Virol.201210.1128/JVI.06232-11 24.De VilliersP.J.SteeleA.D.HiemstraL.A.RappaportR.DunningA.J.GruberW.C.ForrestB.D.Efficacy and safety of a live attenuated" exact="influenza" post="vaccine in adults 60 years of age and olderVaccine20092822823410.1016/j.vaccine.2009.09.09219796721"/>
  <result pre="25.BakerS.F.GuoH.AlbrechtR.A.Garcia-SastreA.TophamD.J.Martinez-SobridoL.Protection against Lethal Influenza with a Viral MimicJ. Virol.2013878591860510.1128/JVI.01081-1323720727 26.PowellT.J.SilkJ.D.SharpsJ.FodorE.TownsendA.R.Pseudotyped" exact="influenza" post="A virus as a vaccine for the induction of"/>
  <result pre="immunityJ. Virol.201286133971340610.1128/JVI.01820-1223015719 27.UrakiR.KisoM.Iwatsuki-HorimotoK.FukuyamaS.TakashitaE.OzawaM.KawaokaY.A novel bivalent vaccine based on a PB2-knockout" exact="influenza" post="virus protects mice from pandemic H1N1 and highly pathogenic"/>
  <result pre="Virol.2013877874788110.1128/JVI.00076-1323658445 28.KatsuraH.Iwatsuki-HorimotoK.FukuyamaS.WatanabeS.SakabeS.HattaY.MurakamiS.ShimojimaM.HorimotoT.KawaokaY.A replication-incompetent virus possessing an uncleavable hemagglutinin as an" exact="influenza" post="vaccineVaccine2012306027603310.1016/j.vaccine.2012.07.05922867723 29.collab: World Health Organization (WHO)Recommendations to assure the"/>
  <result pre="Organization (WHO)Recommendations to assure the quality, safety and efficacy of" exact="influenza" post="vaccines (human, live attenuated) for intranasal administrationWHO Tech. Rep."/>
  <result pre="Influenza Vaccine EffectivenessWHOGeneva, Switzerland2016 31.RudenkoL.YeolekarL.KiselevaI.Isakova-SivakI.Development and approval of live attenuated" exact="influenza" post="vaccines based on Russian master donor viruses: Process challenges"/>
  <result pre="storiesVaccine2016345436544110.1016/j.vaccine.2016.08.01827593158 32.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 33.SnyderM.H.BettsR.F.DeBordeD.TierneyE.L.ClementsM.L.HerringtonD.SearsS.D.DolinR.MaassabH.F.MurphyB.R.Four viral genes independently"/>
  <result pre="(H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 33.SnyderM.H.BettsR.F.DeBordeD.TierneyE.L.ClementsM.L.HerringtonD.SearsS.D.DolinR.MaassabH.F.MurphyB.R.Four viral genes independently contribute to attenuation of live" exact="influenza" post="A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccinesJ. Virol.1988624884953336068 34.Isakova-SivakI.ChenL.M.MatsuokaY.VoetenJ.T.KiselevaI.HeldensJ.G.den"/>
  <result pre="phenotype of a master donor virus used in live attenuated" exact="influenza" post="vaccines: A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 35.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated"/>
  <result pre="influenza vaccines: A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 35.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated" exact="influenza" post="virus that permits in vivo analysis of enhancements to"/>
  <result pre="vivo analysis of enhancements to the safety of live attenuated" exact="influenza" post="virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 36.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in"/>
  <result pre="36.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34" exact="influenza" post="virus by transferring the genetic signature for temperature sensitivity"/>
  <result pre="from cold-adapted A/Ann Arbor/6/60J. Virol.20047899599810.1128/JVI.78.2.995-998.200414694130 37.ZhouB.LiY.SpeerS.D.SubbaA.LinX.WentworthD.E.Engineering temperature sensitive live attenuated" exact="influenza" post="vaccines from emerging virusesVaccine2012303691370210.1016/j.vaccine.2012.03.02522449422 38.NogalesA.RodriguezL.DeDiegoM.L.TophamD.J.Martinez-SobridoL.Interplay of PA-X and NS1"/>
  <result pre="39.BroadbentA.J.SantosC.P.GodboutR.A.SubbaraoK.The temperature-sensitive and attenuation phenotypes conferred by mutations in the" exact="influenza" post="virus PB2, PB1, and NP genes are influenced by"/>
  <result pre="origin of the PB2 gene in reassortant viruses derived from" exact="influenza" post="A/California/07/2009 and A/WSN/33 virusesJ. Virol.201488123391234710.1128/JVI.02142-1425122786 40.CzakoR.VogelL.SuttonT.MatsuokaY.KrammerF.ChenZ.JinH.SubbaraoK.H5N2 vaccine viruses on"/>
  <result pre="Virol.201488123391234710.1128/JVI.02142-1425122786 40.CzakoR.VogelL.SuttonT.MatsuokaY.KrammerF.ChenZ.JinH.SubbaraoK.H5N2 vaccine viruses on Russian and US live attenuated" exact="influenza" post="virus backbones demonstrate similar infectivity, immunogenicity and protection in"/>
  <result pre="protection in ferretsVaccine2018361871187910.1016/j.vaccine.2018.02.06129503113 41.ChenZ.BazM.LuJ.PaskelM.SantosC.SubbaraoK.JinH.MatsuokaY.Development of a high-yield live attenuated H7N9" exact="influenza" post="virus vaccine that provides protection against homologous and heterologous"/>
  <result pre="Pandemic Live Attenuated Influenza Virus VaccinationFront. Immunol.2015628710.3389/fimmu.2015.0028726082783 43.Martinez-SobridoL.Garcia-SastreA.Generation of recombinant" exact="influenza" post="virus from plasmid DNAJ. Vis. Exp.201010.3791/2057 44.GrimmD.StaeheliP.HufbauerM.KoernerI.Martinez-SobridoL.SolorzanoA.Garcia-SastreA.HallerO.KochsG.Replication fitness determines"/>
  <result pre="plasmid DNAJ. Vis. Exp.201010.3791/2057 44.GrimmD.StaeheliP.HufbauerM.KoernerI.Martinez-SobridoL.SolorzanoA.Garcia-SastreA.HallerO.KochsG.Replication fitness determines high virulence of" exact="influenza" post="A virus in mice carrying functional Mx1 resistance geneProc."/>
  <result pre="carrying functional Mx1 resistance geneProc. Natl. Acad. Sci. USA20071046806681110.1073/pnas.070184910417426143 45.KilbourneE.D.Future" exact="influenza" post="vaccines and the use of genetic recombinantsBull. World Health"/>
  <result pre="the NS Gene for Vaccine DevelopmentJ. Virol.201488105251054010.1128/JVI.01565-1424965472 47.SchickliJ.H.FlandorferA.NakayaT.Martinez-SobridoL.Garcia-SastreA.PaleseP.Plasmid-only rescue of" exact="influenza" post="A virus vaccine candidatesPhilos. Trans. R. Soc. Lond. B"/>
  <result pre="ImmunityPLoS ONE201611e016427410.1371/journal.pone.016424727727324 53.BelsheR.LeeM.S.WalkerR.E.StoddardJ.MendelmanP.M.Safety, immunogenicity and efficacy of intranasal, live attenuated" exact="influenza" post="vaccineExpert Rev. Vaccines2004364365410.1586/14760584.3.6.64315606348 54.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.T.C.E.S.Live attenuated versus inactivated influenza vaccine"/>
  <result pre="live attenuated influenza vaccineExpert Rev. Vaccines2004364365410.1586/14760584.3.6.64315606348 54.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.T.C.E.S.Live attenuated versus inactivated" exact="influenza" post="vaccine in infants and young childrenN. Engl. J. Med.200735668569610.1056/NEJMoa06536817301299"/>
  <result pre="Engl. J. Med.200735668569610.1056/NEJMoa06536817301299 55.GorseG.J.BelsheR.B.MunnN.J.Superiority of live attenuated compared with inactivated" exact="influenza" post="A virus vaccines in older, chronically ill adultsChest199110097798410.1378/chest.100.4.9771914615 56.RudenkoL.G.SlepushkinA.N.MontoA.S.KendalA.P.GrigorievaE.P.BurtsevaE.P.RekstinA.R.BeljaevA.L.BraginaV.E.CoxN.et"/>
  <result pre="chronically ill adultsChest199110097798410.1378/chest.100.4.9771914615 56.RudenkoL.G.SlepushkinA.N.MontoA.S.KendalA.P.GrigorievaE.P.BurtsevaE.P.RekstinA.R.BeljaevA.L.BraginaV.E.CoxN.et al.Efficacy of live attenuated and inactivated" exact="influenza" post="vaccines in schoolchildren and their unvaccinated contacts in Novgorod,"/>
  <result pre="RussiaJ. Infect. Dis.199316888188710.1093/infdis/168.4.8818376833 57.SlepushkinA.N.Obrosova-SerovaN.P.BurtsevaE.I.RudenkoL.G.GovorkovaE.A.VartanyanR.V.VerestsinskyA.I.LonskayaN.I.HarmonM.W.TorokT.et al.Comparison of live attenuated and inactivated" exact="influenza" post="vaccines in schoolchildren in Russia: I. Safety and efficacy"/>
  <result pre="Moscow schools, 1987/88Vaccine19931132332810.1016/0264-410X(93)90194-38447161 58.LukarskaM.FournierG.PflugA.Resa-InfanteP.ReichS.NaffakhN.CusackS.Structural basis of an essential interaction between" exact="influenza" post="polymerase and Pol II CTDNature201754111712110.1038/nature2059428002402 59.DeLanoW.L.The PyMOL Molecular Graphics"/>
  <result pre="antibodies (B) and by ELISA for IgG Abs against total" exact="influenza" post="viral proteins using cell extracts of MDCK cells infected"/>
 </snippets>
</snippetsTree>
